Capital Formation Series, Part 3
Crowd-Funding is Coming, But Will it Be Niche Only?
By Trista Morrison
Monday, November 28, 2011
If H.R. 1070 is the capital formation bill likely to have the most immediate impact on biotech by providing an IPO alternative for small companies, then H.R. 2930 which would let private firms raise up to $2 million through crowd-funding might have the most long-term impact by helping start-ups bridge the valley of death.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.